![Study Identifies Benefits, Risks Linked to Popular Weight-Loss Drugs | Newswise Study Identifies Benefits, Risks Linked to Popular Weight-Loss Drugs | Newswise](https://i1.wp.com/www.newswise.com/legacy/image.php?image=/images/uploads/2025/01/15/6787f18466b35_Ziyad-Al-Aly-at-his-desk.jpg&width=600&height=600&w=600&resize=600,400&ssl=1)
Study Identifies Benefits, Risks Linked to Popular Weight-Loss Drugs | Newswise
Newswise — Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study reporting one in eight Americans has taken or is currently using the drugs to treat diabetes, heart disease or obesity. Formally, these drugs are known as glucagon-like peptide-1 receptor agonists (GLP-1RA) and include…